Stock earnings page

Gossamer Bio, Inc. (GOSS)

Track the next or latest earnings date for Gossamer Bio, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

Earnings call transcript: Gossamer Bio Q1 2026 sees revenue beat, EPS miss By Investing.com
www.investing.com · 1 day ago

The company posted an EPS of -$0.20, falling short of the -$0.17 forecast, a miss of 17.65%. However, it significantly outperformed revenue expectations, reporting $16.96 million against a projected $4.71 million, marking a 260.08% surprise. Following the earnings release, Gossamer Bio’s stock ...

Gossamer Bio Balances Seralutinib Promise With Cash Strain - TipRanks.com
www.tipranks.com · 3 days ago

Gossamer Bio ((GOSS)) has held its Q1 earnings call. Read on for the main highlights of the call. Start a conversation with TipRanks’ trusted, data-backed investment intelligence · Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS
www.prnewswire.com · 1 day ago

On this news, Gossamer's stock price fell $1.71 per share, or 80.13%, to close at $0.42 per share on February 23, 2026.

Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update
www.businesswire.com · 5 days ago

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatme...

Gossamer Bio, Inc. (GOSS) Q1 2026 Earnings Call Transcript | Seeking Alpha
seekingalpha.com · 4 days ago

May 18, 2026, 6:10 PM ETGossamer Bio, Inc. (GOSS) Stock ... Gossamer Bio, Inc. (GOSS) Q1 2026 Earnings Call May 18, 2026 8:00 AM EDT

Latest earnings date

Mar 17, 2026

Time not specified

Fiscal quarter: 2025-12-31

EPS estimate: -$0.20

Revenue estimate: N/A

Market cap: $109.20M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Mar 17, 2026	2025-12-31	Time not specified	-$0.20	N/A